Arwa Bohra

Arwa Bohra

Auto-generated profile, based on publicly available information

Arwa Bohra

Division of Hematology, Mayo Clinic, Rochester, MN, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2025 in Leukemia
Verified
Journal Article
Closed access
PDF file
ABArwa Bohra
Arwa Bohra
RHRafla Hassan
Rafla Hassan
Saurabh ZanwarSaurabh Zanwar
Saurabh Zanwar
DJDragan Jevremovic
Dragan Jevremovic
HOHoratiu Olteanu
Horatiu Olteanu
SKShaji Kumar
Shaji Kumar

22 April 2026 in Leukemia
Verified
Journal Article
Closed access
ABArwa Bohra
Arwa Bohra
SDSurendra Dasari
Surendra Dasari
Saurabh ZanwarSaurabh Zanwar
Saurabh Zanwar
WGWilson I. Gonsalves
Wilson I. Gonsalves
PKPrashant Kapoor
Prashant Kapoor
SKShaji Kumar
Shaji Kumar

24 August 2026 in Blood Neoplasia
Verified
Journal Article
Open access
ABArwa Bohra
Arwa Bohra
SDSurendra Dasari
Surendra Dasari
WGWilson I. Gonsalves
Wilson I. Gonsalves
RKRichard K. Kandasamy
Richard K. Kandasamy
PKPrashant Kapoor
Prashant Kapoor
SKShaji Kumar
Shaji Kumar

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
ABArwa Bohra
Arwa Bohra
SAShubham Atal
Shubham Atal
AAAbhishek Anand
Abhishek Anand
SGSagar Goyal
Sagar Goyal
RJRajnish Joshi
Rajnish Joshi
AKAnurag Kanase
Anurag Kanase
Background: SARS-CoV-2 Virus can trigger severe pneumonia and lead to acute respiratory distress syndrome. Data from clinical, in vitro, and in vivo suggest that virus-induced cytokine dysregulation is a contributory factor to the pathogenesis. Drugs targeting the same are being tried. Methods: To obtain a better understanding of the molecular events, we studied the transcriptome of infected macrophages and obtained a list of incriminated pathways using Gene Set Enrichment Analysis. Co-expression gene analysis was further used to predict drug targets. Results: COVID-19 is characterized by a dysregulation of not only immune pathways, but of hemostasis, intercellular signaling, endothelium, cellular protein metabolism, trans-cellular transport and neuronal activity. Interferon alpha, beta, and gamma are upregulated. IL-1,4, 6,10, 12 13, TNF, NF-KB are upregulated. Signaling by NOTCH, and MAP kinase-6, 4 signaling are increased. Olfactory sensation, transmission across chemical synapses, and sperm motility appear to be downregulated. Disease host signature has some resemblance with cystic fibrosis, SARS infection, and diseases of programmed cell death like neurodegenerative diseases. 24 drugs are predicted including Sulindac, Pancuronium, Etamsylate, Ciclosporin, Ciprofloxacin, Valproic Acid, Triamcinolone, Tanespimycin, Tretinoin, Monorden, Scopolamine, Captopril, and Thalidomide. Conclusions: The effectiveness of this approach is demonstrated by the current level of evidence in understanding of COVID-19 pathophysiology. Several drugs of the same drug class have been used in COVID-19 treatment as predicted through the analysis. Further biomarker studies, drug testing on COVID infected cell-lines, and clinical studies are required for validation of obtained results.

25 February 2026 in Leukemia
Verified
Journal Article
Closed access
ABArwa Bohra
Arwa Bohra
RHRafla Hassan
Rafla Hassan
Saurabh ZanwarSaurabh Zanwar
Saurabh Zanwar
DJDragan Jevremovic
Dragan Jevremovic
HOHoratiu Olteanu
Horatiu Olteanu
SKShaji Kumar
Shaji Kumar

9 September 2024 in Indian Journal of Psychological Medicine
Verified
Journal Article
Open access
ABArwa Bohra
Arwa Bohra
MJMili Jyotsna
Mili Jyotsna
SPSai Dheeraj Gowtham Reddy Pereddy
Sai Dheeraj Gowtham Reddy Pereddy
Ananyan SampathAnanyan Sampath
Ananyan Sampath
ARAbhijit R Rozatkar
Abhijit R Rozatkar
SGSnehil Gupta
Snehil Gupta
Backgrounds: Research shows that medical students’ knowledge and skills concerning the assessment of cognition in various neuropsychiatric conditions (e.g., Alzheimer’s disease and schizophrenia) are unsatisfactory. This research aims to conduct a training needs analysis (TNA) for medical students to identify and refer patients with neuropsychiatric conditions. Methods: The study comprised two phases. First, developing a TNA toolkit to assess training needs in clinical tasks related to cognitive function assessment (by adopting the Hennessy–Hicks TNA toolkit); and second, through a self-reported survey, their training needs in cognitive function assessment were assessed. Data analysis involved calculating training gaps, importance scores, performance scores, training scores, and organization scores for various clinical tasks-stratified participants’ study year; for training needs and trends, factor analysis and post-hoc analyses were conducted. Results: A total of 153 medical students from a tertiary care center participated in the survey. The participants rated their performance lower than the perceived importance of tasks, indicating a need for improvement in all competencies ( P < .01). Pre–final-year students had the highest training needs, particularly in accessing literature, planning, and organizing care for patients with cognitive impairment, performing mental status examination, screening patients for cognitive deficits, and counseling them/caregivers about interventions ( P < .01). Factor analysis identified a single dominant factor, suggesting a correlation among these skills. Conclusion: Pre–final-year students require targeted training, whereas students beyond this stage can benefit from special training modules and awareness of available resources for cognitive assessment. The findings also suggest the importance of a hybrid approach involving training and organizational modifications.